Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reduction of TGFβ signaling in myeloid cells in the treatment of cancer

Reduction of TGFβ signaling in myeloid cells in the treatment of cancer

US Patent 9868954 · Granted Jan 16, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Application of circular RNA in preparing drug for treating systemic lupus erythe2025
Fusion proteins for improved precision in base editing2025
Fusion proteins for base editing2024
Inhibition of unintended mutations in gene editing2023
Bifidobacterium animalis and application of compound bacterium preparation prepa2023
Application of valine in preparing medicine for treating or preventing avian inf2023
Inhibition of unintended mutations in gene editing2022
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof2022
MIC-1 receptor and uses thereof2021
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof2019
Hydrophilic electrospinning biological composite stent material used for tissue 2019
Reduction of TGF beta signaling in myeloid cells in the treatment of cancer2017